Cell Point (India)'s EBIT per Share for the
six
months ended in Mar. 2026 was ₹2.24.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3.96.
During the past 12 months, the average EBIT per Share Growth Rate of Cell Point (India) was 67.10% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -26.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -9.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Cell Point (India)'s EBIT per Share or its related term are showing as below:
NSE:CELLPOINT'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -26.8 Med: -10.5 Max: 30.1
Current: -26.8
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Cell Point (India) was 30.10% per year. The lowest was -26.80% per year. And the median was -10.50% per year.
NSE:CELLPOINT's 3-Year EBIT Growth Rate is ranked worse than 87.82% of 887
companies
in the Retail - Cyclical industry
Industry Median: 6.2
vs NSE:CELLPOINT: -26.80
Cell Point (India) (NSE:CELLPOINT) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Cell Point (India) EBIT per Share Related Terms
Cell Point (India) EBIT per Share Historical Data
* Premium members only.
The historical data trend for Cell Point (India)'s EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹3.96
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell Point (India) (NSE:CELLPOINT) has a EBIT per Share of ₹3.96 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Cell Point (India) and its competitors. According to the industry distribution chart, Cell Point (India) ranks #779 out of 887 companies in the Retail - Cyclical industry, placing it in the top 87.8%.
Is Cell Point (India)'s EBIT per Share too high?
Cell Point (India)'s current EBIT per Share is ₹3.96. Based on the distribution chart, Cell Point (India) ranks #779 out of 887 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Cell Point (India) has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s EBIT per Share compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Cell Point (India) ranks #779 out of 887 companies for EBIT per Share. This places Cell Point (India) in the lower half of its industry. The industry median EBIT per Share is 6.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Retail - Cyclical company?
The median EBIT per Share among Retail - Cyclical companies is 6.20, based on 887 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Cell Point (India) and its competitors. For the Retail - Cyclical industry, the median EBIT per Share is 6.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Point (India)'s current EBIT per Share is ₹3.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹34.79, compared to a current price of ₹15.35 — trading 55.9% below its estimated fair value. The current EBIT per Share is ₹3.96. Cell Point (India)'s overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current EBIT per Share is ₹3.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?
Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued.
The current stock price of ₹15.35 is trading 55.9% below its estimated GF Value™ of ₹34.79.
GuruFocus considers Cell Point (India) to be Significantly Undervalued.
Key valuation signals for NSE:CELLPOINT:
EBIT per Share: ₹3.96
GF Value™: ₹34.79 vs. price of ₹15.35 (55.9% below fair value)
No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
76GF Score
Get the complete analysis for NSE:CELLPOINT
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CELLPOINT has been successfully added to your 
